The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer

참고문헌 (145)

1. Zhang, Y., "Exosomes : biogenesis, biologic function and clinical potential", Cell Biosci, 9, pp.19~ (2019)
2. Kalluri, R., "The biology, function, and biomedical applications of exosomes", Science, 367, pp.eaau6977~ (2020)
3. Jan, A., "Biology, pathophysiological role, and clinical implications of exosomes : a critical appraisal", Cells, 8, pp.99~ (2019)
4. Gluszko, A., "The role of tumor-derived exosomes in tumor angiogenesis and tumor progression", Curr. Issues Pharm. Med. Sci, 32, pp.193~202 (2019)
5. da Costa, V. R., "Exosomes in the tumor microenvironment: from biology to clinical applications", Cells, 10, pp.2617~ (2021)
6. Hoshino, A., "Extracellular vesicle and particle biomarkers define multiple human cancers", Cell, 182, pp.1044~1061.e18 (2020)
7. Taghikhani, A., "Engineered tumor-derived extracellular vesicles : potentials in cancer immunotherapy", Front. Immunol, 11, pp.275~280 (2020)
8. Tan, T., "Recent advances in understanding the mechanisms of elemene in reversing drug resistance in tumor cells : a review", Molecules, 26, pp.5792~ (2021)
9. Tang, Z., "The cancer exosomes : clinical implications, applications and challenges", Int. J. Cancer, 146, pp.2946~2959 (2020)
10. Zhang, Y., "Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes", Carcinogenesis, 41, pp.582~590 (2020)
11. Chen, M., "Transcriptome and long noncoding RNA sequencing of three extracellular vesicle subtypes released from the human colon cancer LIM1863cell line", Sci. Rep, 6, pp.38397~ (2016)
12. Del Re, M., "PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC", Br. J. Cancer, 118, pp.820~824 (2018)
13. Lakshmi, S., "Exosomes and exosomal RNAs in breast cancer: a status update", Eur. J. Cancer, 144, pp.252~268 (2021)
14. Schey, K. L., "Proteomics characterization of exosome cargo", Methods, 87, pp.75~82 (2015)
15. Su, Y. Y., "Upregulated expression of serum exosomal miR-375 and miR-1307enhance the diagnostic power of CA125 for ovarian cancer", J. Ovarian Res, 12, pp.6~ (2019)
16. Meng, X., "Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer", Oncotarget, 7, pp.16923~16935 (2016)
17. Jiao, C., "Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma", J. Pediatr. Surg, 52, pp.618~624 (2017)
18. Tang, Y., "Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer", J. Clin. Lab. Anal, 33, pp.e23004~ (2019)
19. Shi, R., "Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients", Oncotarget, 6, pp.26971~26981 (2015)
20. Zhao, R., "Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer", Mole. Cancer, 17, pp.68~ (2018)
21. Işin, M., "Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease", Front. Genet, 6, pp.168~ (2015)
22. Liu, X. H., "Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer", Mol. Cancer, 13, pp.92~ (2014)
23. Zheng, R., "Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression", Mol. Cancer, 17, pp.143~ (2018)
24. Pan, B., "Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer", Front. Genet, 10, pp.1096~ (2019)
25. Allenson, K., "High prevalence of mutant KRAS in circulating exosomederived DNA from early-stage pancreatic cancer patients", Ann. Oncol, 28, pp.741~747 (2017)
26. Castellanos-Rizaldos, E., "Exosome-based detection of EGFR T790M in plasma from non–small cell lung cancer patients", Clin. Cancer Res, 24, pp.2944~2950 (2018)
27. Möhrmann, L., "Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers", Clin. Cancer Res, 24, pp.181~188 (2018)
28. Repetto, O., "Proteomic exploration of plasma exosomes and other small extracellular vesicles in pediatric hodgkin lymphoma : a potential source of biomarkers for relapse occurrence", Diagnostics, 11, pp.917~ (2021)
29. Li, W., "Role of exosomal proteins in cancer diagnosis", Mol. Cancer, 16, pp.145~ (2017)
30. Smolarz, M., "Proteome profiling of exosomes purified from a small amount of human serum : the problem of co-purified serum components", Proteomes, 7, pp.18~ (2019)
31. Liang, Y., "Emerging methods in biomarker identification for extracellular vesicle‐based liquid biopsy", J. Extracell. Vesicles, 10, pp.1003~1009 (2021)
32. Tang, M. K., "Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface", Nat. Commun, 9, pp.2270~ (2018)
33. Wang, N., "Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer", Cancer Sci, 109, pp.1701~1709 (2018)
34. Chen, G., "Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response", Nature, 560, pp.382~386 (2018)
35. Theodoraki, M. -N., "Clinical significance of PD-L1 + exosomes in plasma of head and neck cancer patients", Clin. Cancer Res, 24, pp.896~905 (2018)
36. Lux, A., "c-Met and PD-L1 on circulating exosomes as diagnostic and prognostic markers for pancreatic cancer", Int. J. Mol. Sci, 20, pp.3305~ (2019)
37. Ricklefs, F. L., "Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles", Sci. Adv, 4, pp.2549~2557 (2018)
38. Larios, J., "ALIX-and ESCRT-III–dependent sorting of tetraspanins to exosomes", J. Cell Biol, 219, pp.e201904113~ (2020)
39. Mazurov, D., "Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes", FEBS J, 280, pp.1200~1213 (2013)
40. Malla, R. R., "Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers", Asia. Pac. J. Clin. Oncol, 14, pp.383~391 (2018)
41. Verweij, F. J., "Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling", J. Cell Biol, 217, pp.1129~1142 (2018)
42. Blanc, L., "New insights into the function of Rab GTPases in the context of exosomal secretion", Small GTPases, 9, pp.95~106 (2018)
43. Phuyal, S., "Regulation of exosome release by glycosphingolipids and flotillins", FEBS J, 281, pp.2214~2227 (2014)
44. Mashouri, L., "Exosomes : composition, biogenesis, and mechanisms in cancer metastasis and drug resistance", Mol. Cancer, 18, pp.75~ (2019)
45. Lynch, S., "Novel MHC Class I structures on exosomes", J. Immunol, 183, pp.1884~1891 (2009)
46. Berenguer, J., "Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8", J. Extracell. Vesicles, 7, pp.1446660~ (2018)
47. Chauhan, S., "Surface glycoproteins of exosomes shed by myeloid-derived suppressor cells contribute to function", J. Proteome Res, 16, pp.238~246 (2017)
48. Nazari-Shafti, M.-T., "A monocyte inspired guiding system: targeting of exosomes to ischemia activated microvascular endothelium", 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery (2019)
49. Munich, S., "Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands", Oncoimmunology, 1, pp.1074~1083 (2012)
50. Du, E., "The critical role of the interplays of EphrinB2", EphB4 and VEGF in the induction of angiogenesis, 2020, pp.47, 4681~4690
51. Bhat, A., "Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog–GLI signaling components", Cancer Cell Int, 21, pp.319~ (2021)
52. Feng, Q., "A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis", Nat. Commun, 8, pp.14450~ (2017)
53. Maji, S., "Exosomal annexin II promotes angiogenesis and breast cancer metastasis", Mol. Cancer Res, 15, pp.93~105 (2017)
54. Chiba, M., "Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro", Sci. Rep, 8, pp.11972~ (2018)
55. Horie, K., "Exosomes expressing carbonic anhydrase 9 promote angiogenesis", Biochem. Biophys. Res. Commun, 492, pp.356~361 (2017)
56. Huang, Z., "Exosomes derived from hypoxic colorectal cancer cells transfer Wnt4 to normoxic cells to elicit a prometastatic phenotype", Int. J. Biol. Sci, 14, pp.2094~2102 (2018)
57. Brabletz, T., "EMT in cancer", Nat. Rev. Cancer, 18, pp.128~134 (2018)
58. Kim, H., "The emerging roles of exosomes as EMT regulators in cancer", Cells, 9, pp.861~ (2020)
59. Greening, D. W., "Emerging roles of exosomes during epithelial–mesenchymal transition and cancer progression", Semin. Cell Dev. Biol, 40, pp.60~71 (2015)
60. Gopal, S. K., "Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis", Sci. Rep, 6, pp.28321~ (2016)
61. Shafiq, A., "Transglutaminase-2, RNA-binding proteins and mitochondrial proteins selectively traffic to MDCK cell-derived microvesicles following H-Rasinduced epithelial–mesenchymal transition", Proteomics, 21, pp.2000221~ (2021)
62. Bu, L., "Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment", Oncogene, 38, pp.4887~4901 (2019)
63. Winkler, J., "Concepts of extracellular matrix remodelling in tumour progression and metastasis", Nat. Commun, 11, pp.5120~ (2020)
64. Rilla, K., "Extracellular vesicles are integral and functional components of the extracellular matrix", Matrix Biol, 75–76, pp.201~219 (2019)
65. Pickup, M. W., "The extracellular matrix modulates the hallmarks of cancer", EMBO Rep, 15, pp.1243~1253 (2014)
66. Kim, H. -S., "EMMPRIN expression is associated with metastatic progression in osteosarcoma", BMC Cancer, 21, pp.1059~ (2021)
67. Broner, E. C., "Role of the exosome secretion machinery in ovarian carcinoma: in vitro and in vivo models", J. Oncol, 2020, pp.1~11 (2020)
68. Chengqun, H. E., "Exosomes derived from endoplasmic reticulum-stressed liver cancer cells enhance the expression of cytokines in macrophages via the STAT3 signaling pathway", Oncol. Lett, 20, pp.589~600 (2020)
69. Nagpal, P., "The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes", Cancer Rep. (Hoboken), 4, pp.109~122 (2021)
70. Chen, J., "PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8+ T cell exhaustion during metastasis", Cancer Sci, 112, pp.3437~3454 (2021)
71. Wang, M., "Exosomal proteins : key players mediating pre‑metastatic niche formation and clinical implications(Review)", Int. J. Oncol, 58, pp.4~ (2021)
72. Peinado, H., "Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET", Nat. Med, 18, pp.883~891 (2012)
73. Guo, D., "Rab27a, a novel marker for melanoma metastasis and poor prognosis", Australas. J. Dermatol, 3, pp.349~360 (2018)
74. Costa-Silva, B., "Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver", Nat. Cell Biol, 17, pp.816~826 (2015)
75. Hoshino, A., "Tumour exosome integrins determine organotropic metastasis", Nature, 527, pp.329~335 (2015)
76. Wang, M., "Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a", Oncogene, 40, pp.2296~2308 (2021)
77. Lee, S., "Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1", Cdk2 signaling, 2020, pp.225, 16~22
78. Ji, R., "Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer", Cell Cycle, 14, pp.2473~2483 (2015)
79. Zhou, J., "Mesenchymal stem cell derived exosomes in cancer progression, metastasis and drug delivery : a comprehensive review", J. Cancer, 9, pp.3129~3137 (2018)
80. Pan, Y., "Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner", Cell Biol. Int, 45, pp.858~868 (2021)
81. Qi, R., "Microfluidic device for the analysis of MDR cancerous cell-derived exosomes’ response to nanotherapy", Biomed. Microdevices, 21, pp.35~ (2019)
82. Li, C., "Effects of Michigan Cancer Foundation-7", A new adriamycin cell-derived exosomes on MCF-7 cell apoptosis and drug sensitivity through ubiquitin carboxyl-terminal hydrolase L1, 2020, pp.10, 1780~1785
83. Registry, P. C., "Global cancer observatory", Malays. Cancer Stat, 9, pp.706~712 (2019)
84. Risha, Y., "The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers", Sci. Rep, 10, pp.13572~ (2020)
85. Melo, S. A., "Glypican-1 identifies cancer exosomes and detects early pancreatic cancer", Nature, 523, pp.177~182 (2015)
86. Moon, P. -G., "Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer", Oncotarget, 7, pp.40189~40199 (2016)
87. Moon, P. -G., "Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel biomarker for early breast cancer detection", Clin. Cancer Res, 22, pp.1757~1766 (2016)
88. Li, K., "Survivin in breast cancer–derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis", J. Biol. Chem, 295, pp.13737~13752 (2020)
89. Wang, Y. -T., "Proteomic analysis of exosomes for discovery of protein biomarkers for prostate and bladder cancer", Cancers(Basel), 12, pp.2335~ (2020)
90. Jeppesen, D. K., "Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors", Proteomics, 14, pp.699~712 (2014)
91. Dhondt, B., "Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine", J. Extracell. Vesicles, 9, pp.1736935~ (2020)
92. Øverbye, A., "Identification of prostate cancer biomarkers in urinary exosomes", Oncotarget, 6, pp.30357~30376 (2015)
93. Wu, S., "Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer", Mol. Cancer, 20, pp.17~ (2021)
94. Clark, D. J., "Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes", J. Proteom, 133, pp.161~169 (2016)
95. Park, J. O., "Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions", Proteomics, 13, pp.2125~2134 (2013)
96. Fan, Y., "High-sensitive and multiplex biosensing assay of NSCLC-derived exosomes via different recognition sites based on SPRi array", Biosens. Bioelectron, 154, pp.112066~ (2020)
97. Sandfeld-Paulsen, B., "Exosomal proteins as prognostic biomarkers in nonsmall cell lung cancer", Mol. Oncol, 10, pp.1595~1602 (2016)
98. Jakobsen, K. R., "Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma", J. Extracell. Vesicles, 4, pp.26659~ (2015)
99. Xiao, Y., "Exosomes as potential sources of biomarkers in colorectal cancer", Cancer Lett, 476, pp.13~22 (2020)
100. Mallegol, J., "T84-intestinal epithelial exosomes bear MHC Class II", peptide complexes potentiating antigen presentation by dendritic cells, 2007, pp.132, 1866~1876
101. Suwakulsiri, W., "Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines", Biochim. Biophys. Acta Proteins Proteom, 1867, pp.140171~ (2019)
102. Novikova, S., "Proteomic approach for searching for universal, tissue-specific, and line-specific markers of extracellular vesicles in lung and colorectal adenocarcinoma cell lines", Int. J. Mol. Sci, 21, pp.6601~ (2020)
103. Sun, Z., "Proteomics-based identification of candidate exosomal glycoprotein biomarkers and their value for diagnosing colorectal cancer", Front. Oncol, 11, pp.1293~1300 (2021)
104. Rai, A., "Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome", Proteomics, 19, pp.1800148~ (2019)
105. Li, C., "Integrated omics of metastatic colorectal cancer", Cancer Cell, 38, pp.734~747.e9 (2020)
106. Im, K., "The comparison of exosome and exosomal cytokines between young and old individuals with or without gastric cancer", Int. J. Gerontol, 12, pp.233~238 (2018)
107. Zhang, H., "Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis", Nat. Commun, 8, pp.15016~ (2017)
108. Yoon, J. H., "The diagnostic value of serum gastrokine 1(GKN1)protein in gastric cancer", Cancer Med, 8, pp.5507~5514 (2019)
109. Yoon, J. H., "Gastrokine 1 protein is a potential theragnostic target for gastric cancer", Gastric Cancer, 21, pp.956~967 (2018)
110. Arbelaiz, A., "Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma", Hepatology, 66, pp.1125~1143 (2017)
111. Forner, A., "Hepatocellular carcinoma", Lancet, 391, pp.1301~1314 (2018)
112. Fu, Q., "Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer", Oncogene, 37, pp.6105~6118 (2018)
113. Wang, X., "14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes", Cell Death Dis, 9, pp.159~ (2018)
114. Charkhchi, P., "CA125 and ovarian cancer : a comprehensive review", Cancers(Basel), 12, pp.3730~ (2020)
115. Ahmed, A. A., "Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels", Curr. Probl. Cancer, 43, pp.450~460 (2019)
116. Runz, S., "Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM", Gynecol. Oncol, 107, pp.563~571 (2007)
117. Esfandyari, S., "Exosomes as biomarkers for female reproductive diseases diagnosis and therapy", Int. J. Mol. Sci, 22, pp.2165~ (2021)
118. Chanteloup, G., "Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours : a pilot study", Pilot Feasibility Stud, 6, pp.35~ (2020)
119. Sharma, S., "Exosomal miRNAs and proteins signature as prognostic biomarkers for early stage epithelial ovarian cancer", J. Extracell. Vesicles, 8, pp.60~61 (2019)
120. Tan, L., "Diagnostic accuracy and ability to reduce unnecessary FNAC: a comparison between four Thyroid Imaging Reporting Data System (TI-RADS) versions", Clin. Imaging, 65, pp.133~137 (2020)
121. Luo, D., "Proteomics study of serum exosomes from papillary thyroid cancer patients", Endocr. Relat. Cancer, 25, pp.879~891 (2018)
122. Caruso Bavisotto, C., "Exosomal HSP60 : a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment", Expert Rev. Mol. Diagn, 17, pp.815~822 (2017)
123. Caruso Bavisotto, C., "Immunomorphological pattern of molecular chaperones in normal and pathological thyroid tissues and circulating exosomes : potential use in clinics", Int. J. Mol. Sci, 20, pp.4496~ (2019)
124. Rageh, T. M., "Preoperative significance of thyroglobulin, thyroid stimulating hormone and thyroglobulin antibody in differentiated papillary thyroid carcinoma", Int. Surg. J, 6, pp.4229~ (2019)
125. Huang, T., "Urinary exosomal thyroglobulin : a new biomarker for post-operative follow-up in patients with thyroid cancer", Thyroid, 9, pp.23~27 (2018)
126. Buscail, E., "High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery", Cancers(Basel), 11, pp.1656~ (2019)
127. Zhou, C., "High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma", Cancer Med, 7, pp.5525~5533 (2018)
128. Frampton, A. E., "Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden", Oncotarget, 9, pp.19006~19013 (2018)
129. Casari, I., "Exosomal integrins and their influence on pancreatic cancer progression and metastasis", Cancer Lett, 507, pp.124~134 (2021)
130. Si, Y., "Targeted exosomes for drug delivery : biomanufacturing, surface tagging, and validation", Biotechnol. J, 15, pp.1900163~ (2020)
131. Kučuk, N., "Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers", Int. J. Mol. Sci, 22, pp.9543~ (2021)
132. Villata, S., "EVs and bioengineering : from cellular products to engineered nanomachines", Int. J. Mol. Sci, 21, pp.6048~ (2020)
133. Gutierrez-Millan, C., "Advances in exosomes-based drug delivery systems", Macromol. Biosci, 21, pp.2000269~ (2021)
134. Schindler, C., "Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency", PLoS One, 14, pp.e0214545~ (2019)
135. Li, Z., "Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes : a proof-of-concept study", J. Extracell. Vesicles, 9, pp.1816710~ (2020)
136. Wang, Q., "Plasma membrane-derived extracellular microvesicles mediate non-canonical intercellular NOTCH signaling", Nat. Commun, 8, pp.709~ (2017)
137. Wang, Q., "ARMMs as a versatile platform for intracellular delivery of macromolecules", Nat. Commun, 9, pp.960~ (2018)
138. Votteler, J., "Designed proteins induce the formation of nanocagecontaining extracellular vesicles", Nature, 540, pp.292~295 (2016)
139. Ovchinnikova, L. A., "Reprogramming extracellular vesicles for protein therapeutics delivery", Pharmaceutics, 13, pp.768~ (2021)
140. Xu, Z., "Exosome-based immunotherapy : a promising approach for cancer treatment", Mol. Cancer, 19, pp.160~ (2020)
141. Pi, Y. -N., "Exosomes : powerful weapon for cancer nano-immunoengineering", Biochem. Pharmacol, 186, pp.114487~ (2021)
142. Arima, Y., "Effects of localization of antigen proteins in antigen-loaded exosomes on efficiency of antigen presentation", Mol. Pharm, 16, pp.2309~2314 (2019)
143. Chanteloup, G., "Monitoring HSP70 exosomes in cancer patients’ follow up : a clinical prospective pilot study", J. Extracell. Vesicles, 9, pp.1766192~ (2020)
144. Albakova, Z., "HSP70 multi-functionality in cancer", Cells, 9, pp.587~ (2020)
145. Taha, E. A., "Roles of extracellular HSPs as biomarkers in immune surveillance and immune evasion", Int. J. Mol. Sci, 20, pp.4588~ (2019)

관련 논문AI추천